Lilly Corporate Center
Indianapolis, IN 46285
United States
317 276 2000
https://www.lilly.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - General
Funcionários Integrais: 43.000
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. David A. Ricks | Chairman, CEO & President | 6,29M | N/A | 1968 |
Ms. Anat Ashkenazi | Executive VP & CFO | 2,96M | N/A | 1973 |
Dr. Daniel M. Skovronsky M.D., Ph.D. | EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology | 3,82M | N/A | 1974 |
Ms. Anat Hakim J.D. | Executive VP, General Counsel & Secretary | 2,81M | N/A | 1969 |
Mr. Jacob S. Van Naarden | Executive VP & President of Loxo | 2,38M | N/A | 1985 |
Mr. Donald A. Zakrowski | Senior VP of Finance & Chief Accounting Officer | N/A | N/A | N/A |
Mr. Diogo Rau | EVP & Chief Information and Digital Officer | 1,06M | N/A | 1975 |
Mr. Alonzo Weems | EVP of Enterprise Risk Management and Chief Ethics & Compliance Officer | N/A | N/A | 1972 |
Mr. Eric Dozier | Executive Vice President of Human Resources & Diversity | N/A | N/A | 1968 |
Mr. Jeffrey N. Simmons | Senior VP & President of Elanco Animal Health | 1,73M | N/A | 1967 |
O QualityScore de governança da ISS da Eli Lilly and Company a partir de 1 de abril de 2024 é 6. As principais pontuações para Auditoria são: 3; Conselho: 5; Direitos de Acionistas: 9; Compensação: 1.